Botulinum toxin A for treatment of neurogenic detrusor overactivity and incontinence in patients with spinal cord lesions

Scandinavian Journal of Urology and Nephrology

Volumn 38, Issue 6, 2004, Pages 495-498

  Bagi, Per ^a   Biering Sørensen, Fin ^a  

^a Rigshospitalet   (Denmark)

Author keywords

Botulinum toxin A; Incontinence; Neurogenic detrusor overactivity; Spinal cord lesions

Indexed keywords

BOTULINUM TOXIN A; CHOLINERGIC RECEPTOR BLOCKING AGENT; CIPROFLOXACIN; NIFEDIPINE; TOLTERODINE;

ADULT; AGED; ANTIBIOTIC PROPHYLAXIS; ARTICLE; AUTONOMIC HYPERREFLEXIA; BLADDER CAPACITY; BLADDER FILLING; CLINICAL ARTICLE; CONTROLLED STUDY; CYSTOMETRY; CYSTOSCOPY; DETRUSOR MUSCLE; DISEASE SEVERITY; DRUG EFFICACY; FEMALE; HEMATURIA; HUMAN; MALE; NEUROGENIC BLADDER; NEUROGENIC DETRUSOR OVERACTIVITY; PRIORITY JOURNAL; SIDE EFFECT; SPINAL CORD LESION; TREATMENT OUTCOME; URINE INCONTINENCE;

ADMINISTRATION, INTRAVESICAL; ADULT; AGED; BOTULINUM TOXIN TYPE A; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; MUSCLE HYPERTONIA; MUSCLE, SMOOTH; NEUROMUSCULAR AGENTS; SPINAL CORD NEOPLASMS; TREATMENT OUTCOME; URINARY BLADDER, NEUROGENIC; URINARY INCONTINENCE; URODYNAMICS;

EID: 10844294338     PISSN: 00365599     EISSN: None     Source Type: Journal    
DOI: 10.1080/00365590410015867     Document Type: Article

References (12)

1. Biering-Sørensen F, Nielans HM, Dørflinger T, et al. Urological situation five years after spinal cord injury. Scand J Urol Nephrol 1999; 33: 157-61.
2. Wein AJ. Neuromuscular dysfunction of lower urinary tract. In: Walsh PC, Retik AB, Darracott Vaughan E Jr, editors. Campbell's urology. Philadelphia, PA: Saunders; 1998. p. 953-1006.
3. Abrams P, Khoury S, Wein A, editors. Incontinence. 1st International Consultation on Incontinence. Plymouth, UK: Health Publications; 1999. p. 105-54.
4. Schurch B, Kramer G, Schmid DM, Gaul G, Hauri D. Botulinum-A toxin detrusor injections in the treatment of detrusor hyperreflexia. J Urol 1999; 163 (Suppl 4): 244.
5. Reitz A, Stöhrer M, Kramer G, Del Popolo G, Charlier-Kastler E, Panneck J, et al. European experience of 200 cases treated with Botulinum-A toxin injections into the detrusor muscle for neurogenic incontinence. Eur Urol 2003; Suppl 2: 140.
6. Abrams P, Cardozo L, Fall M, Griffiths D, Rosier P, Ulmsten U, et al. The standardization of terminology of lower urinary tract function: report from the Standardisation Sub-committee of the International Continence Society. Neurourol Urodyn 2002; 21: 167-78.
7. Schurch B, Stöhrer M, Kramer G, Schmid DM, Gaul G, Hauri D. Botulinum-A toxin for treating detrusor hyperreflexia in spinal cord injured patients: a alternative to anticholinergic drugs? Preliminary results. J Urol 2000; 164: 692.
8. Siegel S, Castellan NJ Jr. Nonparametric statistics for behavioral sciences. New York: McGraw-Hill; 1988.
9. Staehler M, Sauter T, Miller K. Long term results prove Botulinum toxin A injection in the m. detrusor vesicae to be an alternative to surgery in children with myelomeningocele. Eur Urol 2003; Suppl 2: 140.
10. Grosse JO, Kramer AEJJ, Löchner-Ernst D, St'ohrer M. Success of repeat detrusor injections of Botulinum A toxin in patients with severe neurogenic detrusor overactivity and incontinence. Eur Urol 2003; Suppl 2: 141.
11. Leipold T, Reitz A, Schurch B. Botulinum toxin as a new therapy option for voiding disorders; current state of the art. Eur Urol 2003; 44: 165-74.
12. Wyndale JJ, Van Dromme SA. Muscular weakness as side effect of botulinum toxin injection for neurogenic detrusor overactivity. Spinal Cord 2002; 40: 599-600.